Scientific and clinic highlights from the 15th International Symposium on MND

United States; amyotrophic lateral sclerosis; artificial ventilation; aspiration pneumonia; athlete; caloric intake; clinical trial; cognition; cognitive defect; conference paper; disease course; disease marker; drug efficacy; drug safety; dysphagia; electrostimulation; environmental exposure; environmental factor; esophagus manometry; gastrointestinal toxicity; gene mutation; health status; high risk population; human; hyperbaric oxygen; interdisciplinary communication; interpersonal communication; motor neuron disease; nerve cell degeneration; nerve fiber transport; nonhuman; nutritional support; palliative therapy; patient care; practice guideline; priority journal; quality of life; risk assessment; sleep disordered breathing; sleep; surface enhanced laser desorption ionization time of flight mass spectrometry; symposium; treatment outcome; 3 nitrotyrosine; biological marker; celecoxib; endavarone; herbicide; neurotoxin; oxygen; pentoxifylline; porphyrin derivative; porphyrin manganese; scavenger; tamoxifen; ubidecarenone; unclassified drug; vasculotropin